This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Technologies and Novel Platforms for Optimizing Cell and Gene Therapies

Share this article

While there is so much demand for drug development in the cell and gene sector, there is a thirst for solutions to achieve scalability while driving down high costs.

In the first edition in a brand new Cell & Gene Therapy eBook Series, we explore which technologies can address the sector’s biggest and most unique challenges across areas such as the use of vectors, AAV quantification and qPCR assays, and the best ways to introduce automation.

The ebook includes:

  • Evaluating Biodistribution and Shedding in Gene and Cell Therapies
  • Cell and Gene Therapy Survey Report 2020: Viral and Non-viral Vectors
  • Using Automation in Cell and Gene Therapy Manufacturing
  • Rapid, Automated, At-line AAV Virus Quantitation Advances Bioprocessing in Gene Therapy

Click the image below to begin exploring the ebook.

eBook: Technologies and novel platforms for optimizing cell and gene therapies

Share this article

Upcoming event

Cell & Gene Therapy Manufacturing & Commercialization US

23 - 26 Sep 2024, Boston, MA

The Cell and Gene Therapy Event for Ground-Breaking Manufacturing, Commercialization and Supply Chain Strategies

Go to site